Literature DB >> 7844435

Laboratory induced resistance to praziquantel in experimental schistosomiasis.

M M Ismail1, S A Taha, A M Farghaly, A S el-Azony.   

Abstract

To study the effect of praziquantel (PZQ) on successive generations of S. mansoni worms, infected mice were treated 6 weeks after infection with different doses of PZQ (300, 500 mg/kg.), the schistosome strain was originally obtained from an infected Egyptian patient. The eggs subsequently produced by worms that had survived the PZQ treatment were used to infect snails and mice of the following generations. The results were expressed as average number of worms and cure rates in comparison with control groups. It was found that the use of PZQ., especially in low subcurative dose may lead to the development of resistance to therapeutic dose of the drug in following generations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7844435

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  19 in total

Review 1.  Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.

Authors:  Nuno Vale; Maria João Gouveia; Gabriel Rinaldi; Paul J Brindley; Fátima Gärtner; José M Correia da Costa
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Susceptibility or resistance of praziquantel in human schistosomiasis: a review.

Authors:  Wei Wang; Li Wang; You-Sheng Liang
Journal:  Parasitol Res       Date:  2012-10-07       Impact factor: 2.289

Review 3.  Population Structure and Dynamics of Helminthic Infection: Schistosomiasis.

Authors:  Ronald E Blanton
Journal:  Microbiol Spectr       Date:  2019-07

Review 4.  Application of praziquantel in schistosomiasis japonica control strategies in China.

Authors:  Wei Wu; Yixin Huang
Journal:  Parasitol Res       Date:  2013-01-29       Impact factor: 2.289

5.  Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?

Authors:  Wei Wang; Hong-Jun Li; Guo-Li Qu; Yun-Tian Xing; Zhen-Kun Yang; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

Review 6.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

7.  A schistosome cAMP-dependent protein kinase catalytic subunit is essential for parasite viability.

Authors:  Brett E Swierczewski; Stephen J Davies
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25

8.  Parasitemia Evaluation in Mice Infected with Schistosoma mansoni.

Authors:  Naiara Clemente Tavares; Marina Moraes Mourão
Journal:  Bio Protoc       Date:  2021-05-20

Review 9.  Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Authors:  José T Moreira-Filho; Arthur C Silva; Rafael F Dantas; Barbara F Gomes; Lauro R Souza Neto; Jose Brandao-Neto; Raymond J Owens; Nicholas Furnham; Bruno J Neves; Floriano P Silva-Junior; Carolina H Andrade
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

10.  Comparative study of transcriptome profiles of mechanical- and skin-transformed Schistosoma mansoni schistosomula.

Authors:  Anna V Protasio; David W Dunne; Matthew Berriman
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.